Pre-operative predictors of post-operative seizure control in low-grade glioma: a systematic review and meta-analysis
Tóm tắt
As many as 80% of low-grade gliomas (LGGs) present with seizures, negatively impacting quality of life. While seizures are associated with gliomas regardless of grade, the importance of minimizing impact of seizures for patients with low grade tumors cannot be understated given the prolonged survival period in this population. The objective of this systematic review and meta-analysis was to summarize existing literature and identify factors associated with post-operative seizure control (defined as Engel I classification) in patients with LGGs, with a focus on pre-operative factors. Patient data extracted include tumor location and histology, pre-operative anti-seizure medication use, extent of resection (EOR), adjuvant treatment, pre-operative seizure type, duration, and frequency, and post-operative Engel classification. A random-effects model was used to calculate the effects of EOR, pre-operative seizure duration, adjuvant radiation, and adjuvant chemotherapy on post-operative seizure control. The effect of tumor location and histology on post-operative Engel I classification was determined using contingency analyses. Thirteen studies including 1628 patients with seizures were included in the systematic review. On meta-analyses, Engel I classification was associated with pre-operative seizure type (OR = 0.79 (0.63–0.99), p = 0.0385, focal versus generalized), frontal lobe LGGs (OR = 1.5 (1.1–2.0), p = 0.0195), and EOR (OR (95% CI) = 4.5 (2.3–6.7), p < 0.0001 gross-total versus subtotal). Pre-operative seizure duration less than one year, adjuvant radiation, adjuvant chemotherapy, and tumor histology were not associated with achieving Engel I classification. In addition to the known effects of EOR, Engel I classification is less likely to be achieved in patients with focal pre-operative seizures and more likely to be achieved in patients with frontal lobe LGGs.
Từ khóa
Tài liệu tham khảo
Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro Oncol Oct 5(12 Suppl 2):iii1–iii105. https://doi.org/10.1093/neuonc/noab200
Kerkhof M, Vecht CJ (2013) Seizure characteristics and prognostic factors of gliomas. Epilepsia 54:12–17
Chang EF, Potts MB, Keles GE et al (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg Feb 108(2):227–235. https://doi.org/10.3171/jns/2008/108/2/0227
You G, Sha ZY, Yan W et al (2012) Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. Neuro Oncol Feb 14(2):230–241. https://doi.org/10.1093/neuonc/nor205
Pallud J, Audureau E, Blonski M et al (2014) Epileptic seizures in diffuse low-grade gliomas in adults. Brain 137(2):449–462
Klein M, Engelberts NH, van der Ploeg HM et al (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol Oct 54(4):514–520. https://doi.org/10.1002/ana.10712
Ray S, Bonafede MM, Mohile NA (2014) Treatment patterns, survival, and healthcare costs of patients with malignant gliomas in a large US commercially insured population. Am Health Drug Benefits May 7(3):140–149
Bai SC, Xu BN, Wei SH et al (2015) Intraoperative high-field magnetic resonance imaging combined with functional neuronavigation in resection of low-grade temporal lobe tumors. World J Surg Oncol 13:286. https://doi.org/10.1186/s12957-015-0690-7
He X, Zhang K, Liu D, Yang Z, Li X, Yang Z (2023) Predictors of seizure outcomes in patients with diffuse low-grade glioma-related epilepsy after complete glioma removal. CNS Neurosci Ther 29(2):736–743. https://doi.org/10.1111/cns.14061
Meguins LC, Adry RA, Silva Júnior SC et al (2015) Gross-total resection of temporal low grade gliomas is a critically important factor in achieving seizure-freedom. Arq Neuropsiquiatr Nov 73(11):924–928. https://doi.org/10.1590/0004-282x20150141
Ius T, Pauletto G, Tomasino B et al (2020) Predictors of postoperative seizure outcome in low grade glioma: from volumetric analysis to molecular stratification. Cancers (Basel) 12(2). https://doi.org/10.3390/cancers12020397
Mehrotra A, Singh S, Kanjilal S et al (2020) Long-term epilepsy-associated tumors (LEATs): a Single-center, retrospective series and review of literature on factors affecting the seizure outcome. World Neurosurg 144:e149–e155. https://doi.org/10.1016/j.wneu.2020.08.036
Page MJ, Moher D, Bossuyt PM et al (2021) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 372
Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924–926. https://doi.org/10.1136/bmj.39489.470347.AD
Sterne JA, Hernán MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355
Veroniki AA, Jackson D, Viechtbauer W et al (2016) Methods to estimate the between-study variance and its uncertainty in meta‐analysis. Res Synthesis Methods 7(1):55–79
Ius T, Pauletto G, Isola M et al (2014) Surgery for insular low-grade glioma: predictors of postoperative seizure outcome. J Neurosurg Jan 120(1):12–23. https://doi.org/10.3171/2013.9.Jns13728
Jiang H, Liu B, Deng G et al (2020) Short-term outcomes and predictors of post-surgical seizures in patients with supratentorial low-grade gliomas. J Clin Neurosci Feb 72:163–168. https://doi.org/10.1016/j.jocn.2019.12.034
Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1–48
McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol May 15(10):940–943. https://doi.org/10.1093/aje/kwg074
Ruban D, Byrne RW, Kanner A et al (2009) Chronic epilepsy associated with temporal tumors: long-term surgical outcome. Neurosurg Focus Aug 27(2):E6. https://doi.org/10.3171/2009.5.Focus0998
Feyissa AM, Worrell GA, Tatum WO et al (2018) High-frequency oscillations in awake patients undergoing brain tumor-related epilepsy surgery. Neurol Mar 27(13):e1119–e1125. https://doi.org/10.1212/wnl.0000000000005216
Xu DS, Awad AW, Mehalechko C et al (2018) An extent of resection threshold for seizure freedom in patients with low-grade gliomas. J Neurosurg Apr 128(4):1084–1090. https://doi.org/10.3171/2016.12.Jns161682
Yao PS, Zheng SF, Wang F, Kang DZ, Lin YX (2018) Surgery guided with intraoperative electrocorticography in patients with low-grade glioma and refractory seizures. J Neurosurg Mar 128(3):840–845. https://doi.org/10.3171/2016.11.Jns161296
van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C (1998) Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry May 64(5):581–587. https://doi.org/10.1136/jnnp.64.5.581
Smits A, Duffau H (2011) Seizures and the natural history of World Health Organization grade ii gliomas. Rev Neurosurg 68(5):1326–1333. https://doi.org/10.1227/NEU.0b013e31820c3419
Shan X, Fan X, Liu X, Zhao Z, Wang Y, Jiang T (2018) Clinical characteristics associated with postoperative seizure control in adult low-grade gliomas: a systematic review and meta-analysis. Neuro Oncol Feb 19(3):324–331. https://doi.org/10.1093/neuonc/nox130
Aghi MK, Nahed BV, Sloan AE, Ryken TC, Kalkanis SN, Olson JJ (2015) The role of surgery in the management of patients with diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline. J Neurooncol Dec 125(3):503–530. https://doi.org/10.1007/s11060-015-1867-1
Yang K, Nath S, Koziarz A et al (2018) Biopsy versus subtotal versus gross total resection in patients with low-grade glioma: a systematic review and meta-analysis. World Neurosurg 120:e762–e775. https://doi.org/10.1016/j.wneu.2018.08.163
Pallud J, Audureau E, Blonski M et al (2013) Epileptic seizures in diffuse low-grade gliomas in adults. Brain 137(2):449–462. https://doi.org/10.1093/brain/awt345
Ryken TC, Parney I, Buatti J, Kalkanis SN, Olson JJ (2015) The role of radiotherapy in the management of patients with diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline. J Neurooncol Dec 125(3):551–583. https://doi.org/10.1007/s11060-015-1948-1
Shankar A, Rajshekhar V (2003) Radiological and clinical outcome following stereotactic biopsy and radiotherapy for low-grade insular astrocytomas. Neurol India Dec 51(4):503–506
Taillandier L, Duffau H (2009) Epilepsy and insular grade II gliomas: an interdisciplinary point of view from a retrospective monocentric series of 46 cases. Neurosurg Focus Aug 27(2):E8. https://doi.org/10.3171/2009.6.Focus09102
Kahlenberg CA, Fadul CE, Roberts DW et al (2012) Seizure prognosis of patients with low-grade tumors. Seizure Sep 21(7):540–545. https://doi.org/10.1016/j.seizure.2012.05.014
Koekkoek JA, Kerkhof M, Dirven L, Heimans JJ, Reijneveld JC, Taphoorn MJ (2015) Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review. Neuro Oncol Jul 17(7):924–934. https://doi.org/10.1093/neuonc/nov032
Liubinas SV, D’Abaco GM, Moffat BM et al (2014) IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas. Epilepsia Sep 55(9):1438–1443. https://doi.org/10.1111/epi.12662
Chen H, Judkins J, Thomas C et al (2017) Mutant IDH1 and seizures in patients with glioma. Neurol May 9(19):1805–1813. https://doi.org/10.1212/wnl.0000000000003911
Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol Aug 2(8):1231–1251. https://doi.org/10.1093/neuonc/noab106